TAMAYO LOUIS EDWARD (Chief Financial Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2026ACC: 0002083206-26-000002
Officer· Chief Financial Officer
Since Feb 2026
+271.33K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
271.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+44.66K
Price / share
—
Trade value
—
% of position
99.3%
2/4/2026
45K→89.67K
Total
Net shares
+44.66K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | A · Award | +44.66K | — | — | 99.3% | 45K | 89.67K |
| Total | +44.66K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
226.66K shares
Shares
+226.66K
Strike price
7.27
Held after
226.66K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock226.66K shares | 2/4/2026 | A · Award | +226.66K | 7.27 | — | 226.66K |